Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid carcinoma. Lenvatinib, a multikinase inhibitor, is rarely used in preoperative settings due to adverse effects including delayed wound healing and fistula formation. Herein, we report the use of lenvatinib treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Haruhiko, Masudo, Katsuhiko, Kanada, Sachie, Inayama, Yoshiaki, Hayashi, Hiroyuki, Fujii, Yu, Rino, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017899/
https://www.ncbi.nlm.nih.gov/pubmed/36920674
http://dx.doi.org/10.1186/s40792-023-01619-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017899/
https://www.ncbi.nlm.nih.gov/pubmed/36920674
http://dx.doi.org/10.1186/s40792-023-01619-6

Ejemplares similares